Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

More Satisfied, But Why? A Pooled Patient‐level Analysis Of Treatment Satisfaction Following The Initiation Of Insulin Glargine Vs. Comparators In Insulin‐naïve Patients With Type 2 Diabetes Mellitus

W. Polonsky, L. Traylor, W. Wei, R. Shi, B. Ameer, A. Vlajnic, A. Nicolucci
Published 2014 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
To assess patient‐reported outcomes associated with initiating insulin glargine among insulin‐naïve patients with type 2 diabetes mellitus (T2DM).
This paper references
10.1016/J.JDIACOMP.2006.02.004
Transition to insulin in Type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers.
S. Nakar (2007)
RECOMMANDATIONS 2012 EN DIABÉTOLOGIE: Prise en charge de l'hyperglycémie dans le diabète de type 2: une approche centrée sur le patient
A. Scheen (2012)
10.4324/9781315077369-16
Diabetes Treatment Satisfaction Questionnaire: (DTSQ)
C. Bradley (2013)
10.1007/s00125-012-2534-0
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
S. Inzucchi (2012)
10.1016/J.DIABRES.2007.03.021
Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: the Canadian INSIGHT Study.
R. Houlden (2007)
10.2337/DIACARE.29.04.06.DC05-0053
Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study.
M. Peyrot (2005)
10.1111/j.1463-1326.2008.00871.x
Improving treatment satisfaction and other patient‐reported outcomes in people with type 2 diabetes: the role of once‐daily insulin glargine
C. Bradley (2008)
10.2478/afmnai-2014-0024
Quality of Life in Type 2 Diabetic Patients
A. Spasić (1999)
10.1111/j.1742-1241.2008.01742.x
Primary care physician beliefs about insulin initiation in patients with type 2 diabetes
R. Hayes (2008)
10.2337/DIACARE.28.10.2543
Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem.
W. Polonsky (2005)
10.1016/S0084-3741(08)79214-X
Initiate Insulin by Aggressive Titration and Education (INITIATE): A randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups
J. Leahy (2008)
10.1185/03007995.2011.573623
Are patients with type 2 diabetes reluctant to start insulin therapy? An examination of the scope and underpinnings of psychological insulin resistance in a large, international population
William H. Polonsky (2011)
10.1111/j.1464-5491.2011.03329.x
Initiation of insulin glargine in patients with Type 2 diabetes in suboptimal glycaemic control positively impacts health‐related quality of life. A prospective cohort study in primary care
T. Hajós (2011)
10.2337/DIACARE.22.3.530
Diabetes treatment satisfaction questionnaire. Change version for use alongside status version provides appropriate solution where ceiling effects occur.
C. Bradley (1999)
10.2337/diacare.21.6.919
Well-Being and Symptoms in Relation to Insulin Therapy in Type 2 Diabetes
J. J. J. D. Sonnaville (1998)
10.1056/NEJMoa0806470
10-year follow-up of intensive glucose control in type 2 diabetes.
R. Holman (2008)
10.1185/030079906X115757
Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes
C. Currie (2006)
10.4324/9781315077369
Handbook of Psychology and Diabetes : A Guide to Psychological Measurement in Diabetes Research and Practice
C. Bradley (1994)
10.1016/S0140-6736(98)07019-6
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
UK Prospective Diabetes Study Group (1998)
10.1016/S0168-8227(00)00245-X
Effect of insulin therapy on quality of life in Type 2 diabetes mellitus: The Fremantle Diabetes Study.
T. Davis (2001)
10.2337/DIACARE.28.2.254
Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes.
H. Janka (2005)
10.3109/00016485509120666
The study group.
G. H. Duvel (1980)
10.2337/dc10-1926
Effect of Intensive Glycemic Lowering on Health-Related Quality of Life in Type 2 Diabetes
R. Anderson (2011)
10.2337/DIACARE.26.11.3080
The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.
M. Riddle (2003)
10.1016/j.diabres.2011.10.020
Improvements in quality of life associated with insulin analogue therapies in people with type 2 diabetes: results from the A1chieve observational study.
S. Shah (2011)
Study (UKPDS) Group
UK Prospective Diabete (1998)
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
R. Turner (1998)
10.1186/1477-7525-8-113
Barriers towards insulin therapy in type 2 diabetic patients: results of an observational longitudinal study
N. Hermanns (2010)
10.1016/J.DIABRES.2006.11.002
Glargine versus NPH insulin: efficacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes--the glargine and aspart study (GLASS) a randomised cross-over study.
S. Chatterjee (2007)
10.1186/1477-7525-5-57
The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ
C. Bradley (2007)
10.1185/030079904X5526
The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study*
J. S. Fischer (2004)
Insulin Glargine 4002 Study Investigators. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients
MC Riddle (2003)
10.1016/S1098-3597(09)60006-5
Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus.
D. Marrero (2007)
10.1016/j.diabres.2010.04.002
Effects of insulin initiation on patient-reported outcomes in patients with type 2 diabetes: results from the durable trial.
L. J. Lee (2010)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar